- Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis
-
Shi Yw, Fan JG
- KMID: 2539804
- Clin Mol Hepatol.
- 2023 Feb;29(Suppl):S228-S243.
- doi: 10.3350/cmh.2022.0401
Nonalcoholic steatohepatitis (NASH) is an aggressive form of nonalcoholic fatty liver disease (NAFLD) characterized by steatosis-associated inflammation and liver injury. Without effective treatment or management, NASH can have life-threatening outcomes.... -
- CITED
-
- Close
- SHARE
-
- Close
